To investigate the physiological and pathological relevance of ASF1A in the development of CML in vivo, we established a xenograft tumor model by injecting K562 cells transduced with shRNA against ASF1A (or scrambled shRNA) subcutaneously into NOD-SCID mice. Here, ASF1A is linked to neoplasm.